Greater China: NuProbe raises $50m and 18 more deals worth $377m

Greater China: NuProbe raises $50m and 18 more deals worth $377m

02 June, 2022

AstraZeneca-CICC Fund biotech molecular diagnostics NuProbe Panlin Capital

Printed by Unregistered user on Sat, 05 Jul 2025 13:47:37 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Seek Pet raises $75m and 21 more deal updates from Greater China worth $263m

Venture Capital

China Deal Review: Startup funding value drops 42% to $2.7b in April

Read more from Greater China

China’s EV rivalry spills over to Thailand, tests local production goals

People Digest: responsAbility appoints CEO; Gaw Capital names data centre platform head